Ifp Advisors, Inc Nymox Pharmaceutical Corp Transaction History

Ifp Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$1.3 - $2.23 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$1.46 - $2.48 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$2.22 - $3.39 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$1.84 - $2.83 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$2.3 - $3.66 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$2.1 - $4.6 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$1.69 - $3.88 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$1.73 - $2.42 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$1.41 - $2.12 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$1.57 - $2.71 $8,635 - $14,905	-5,500 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$3.09 - $4.43 $15,635 - $22,415	5,060 Added 1150.0%	5,500 $0
Q2 2016 Jun 03, 2019	BUY	N/A	440	440 $1,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.